Home › NDC Lookup › RxCUI directory › RxCUI 562502

Epoprostenol 1.5 MG Injection — RxCUI 562502

Name: Epoprostenol 1.5 MG Injection (RxCUI 562502)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 562502 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI562502

Official nameEpoprostenol 1.5 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asepoprostenol 1.5 MG (as epoprostenol sodium) Injection

FDA products mapped8

Package NDCs mapped8

Reported Medicaid activity (SDUD)1,316 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Epoprostenol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Epoprostenol breaks down in your bloodstream in about 6 minutes or less, so a pill would be gone before it could do anything. The only way to keep steady levels in your blood — and...
Why do I have to be on a continuous IV infusion — can't I just take a pill?
This is a serious situation. Because epoprostenol leaves your body so quickly, even a brief interruption can cause your lung blood pressure to spike back up — you may suddenly feel...
What happens if my pump stops or the tubing gets disconnected?

📖 Read our full Epoprostenol guide →

🕸️ Concept Web — How Epoprostenol 1.5 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Epoprostenol 1.5 MG Injection RxCUI 562502 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Epoprostenol 8814 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Flolan 114221 BN
- Veletri 1009213 BN
Dose forms 8

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Epoprostenol Injection 1789858 SCDF
- Epoprostenol Injectable Product 1163896 SCDG
- Epoprostenol Injection [Flolan] 1789861 SBDF
- Epoprostenol Injection [Veletri] 1789866 SBDF
- Flolan Injectable Product 1169774 SBDG
- Veletri Injectable Product 1187757 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Epoprostenol 1.5 MG 1789870 SCDC
- Epoprostenol 1.5 MG Injection [Flolan] 211200 SBD
- Epoprostenol 1.5 MG Injection [Veletri] 1009216 SBD
- Epoprostenol 1.5 MG [Flolan] 1789872 SBDC
- Epoprostenol 1.5 MG [Veletri] 1789874 SBDC

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Epoprostenol 1.5 MG SCDC · 1789870
Epoprostenol Injection SCDF · 1789858
Epoprostenol Injectable Product SCDG · 1163896

Brand-Name Concepts

Epoprostenol 1.5 MG Injection [Veletri] SBD · 1009216
Epoprostenol 1.5 MG Injection [Flolan] SBD · 211200
Epoprostenol 1.5 MG [Flolan] SBDC · 1789872
Epoprostenol 1.5 MG [Veletri] SBDC · 1789874
Epoprostenol Injection [Flolan] SBDF · 1789861
Epoprostenol Injection [Veletri] SBDF · 1789866
Flolan Injectable Product SBDG · 1169774
Veletri Injectable Product SBDG · 1187757
Flolan BN · 114221
Veletri BN · 1009213

📦 FDA Products & Package NDCs

8 products · 8 package NDCs

8 package NDCs map to RxCUI 562502 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
62756-0059-40	1 VIAL in 1 CARTON (62756-059-40) / 10 mL in 1 VIAL	epoprostenol	Sun Pharmaceutical Industries, Inc.	2021-01-16
62756-0060-40	1 VIAL in 1 CARTON (62756-060-40) / 10 mL in 1 VIAL	epoprostenol	Sun Pharmaceutical Industries, Inc.	2021-01-16
66215-0402-01	1 VIAL in 1 CARTON (66215-402-01) / 10 mL in 1 VIAL	Veletri	Actelion Pharmaceuticals US, Inc.	2010-04-22
66215-0403-01	1 VIAL in 1 CARTON (66215-403-01) / 10 mL in 1 VIAL	Veletri	Actelion Pharmaceuticals US, Inc.	2010-04-22
67457-0587-10	1 VIAL in 1 CARTON (67457-587-10) / 10 mL in 1 VIAL	EPOPROSTENOL	Mylan Institutional LLC	2024-09-25
67457-0588-10	1 VIAL in 1 CARTON (67457-588-10) / 10 mL in 1 VIAL	EPOPROSTENOL	Mylan Institutional LLC	2024-09-25
68083-0642-01	1 VIAL in 1 CARTON (68083-642-01) / 10 mL in 1 VIAL	Epoprostenol	Gland Pharma Limited	2025-12-29
68083-0707-01	1 VIAL in 1 CARTON (68083-707-01) / 10 mL in 1 VIAL	Epoprostenol	Gland Pharma Limited	2025-12-29

Observed labelers: Actelion Pharmaceuticals US, Inc. (2) · Gland Pharma Limited (2) · Mylan Institutional LLC (2) · Sun Pharmaceutical Industries, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1325	Epoprostenol injection	6	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.